Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this proprietary medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
VISANNE does not provide an improvement in actual benefit (IAB V) in the therapeutic strategy for endometriosis. |
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
UXBhN5eUA785PLjk
Listen
